Reason for request
Inclusion on the list of medicines reimbursed by National Health Insurance and approved for hospital use.
Clinical Benefit
| Substantial |
The actual benefit of this proprietary medicinal product is substantial. |
Clinical Added Value
| no clinical added value |
VISANNE does not provide an improvement in actual benefit (IAB V) in the therapeutic strategy for endometriosis. |
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
UXBhN5eUA785PLjk
Listen
